Göm menyn

Publications for Tove Sivik

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 5 times*

Journal Articles

Erik Hilborn, Tove Sivik, Tommy Fornander, Olle Stål, Bo Nordenskjöld and Agneta Jansson
  C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients
  Breast Cancer Research and Treatment, 2014, 145(1), 73-82.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Tove Sivik, Cecilia Gunnarsson, Tommy Fornander, Bo Nordenskjöld, Lambert Skoog, Olle Stål and Agneta Jansson
  17β-hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer
  PLoS ONE, 2012, 7(7), e40568.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Tove Sivik, Svante Vikingsson, Henrik Gréen and Agneta Jansson
  Expression Patterns of 17β-Hydroxysteroid Dehydrogenase 14 in Human Tissues
  Hormone and Metabolic Research, 2012, 44(13), 949-956.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Tove Sivik and Agneta Jansson
  Progesterone and levonorgestrel regulate expression of 17 beta HSD-enzymes in progesterone receptor positive breast cancer cell line T47D
  Biochemical and Biophysical Research Communications - BBRC, 2012, 422(1), 109-113.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Tove Sivik, Svante Vikingsson, Henrik Greén and Agneta Jansson
  A validated and rapid high-performance liquidchromatography method for the quantification ofconversion of radio-labelled sex steroids
  Hormone Molecular Biology and Clinical Investigation, 2010, 3(1), 375-381.

Agneta Jansson, Cecilia Gunnarsson, Maja Cohen, Tove Sivik and Olle Stål
  17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer
  Cancer Research, 2006, 66(23), 11471-11477.
 Web of Science® Times Cited: 49

Conference Articles

Tove Sivik, Olle Stål, T Fornander, L Skoog, Bo Nordenskjöld and Agneta Jansson
  Significance of 17bHSD Type 14 as a Predictive Factor for Adjuvant Tamoxifen Treatment Response in Breast Cancer in CANCER RESEARCH, vol 69, issue 24, pp 596S-597S

Ph.D. Theses

Tove Sivik
  Elucidating the role of 17β hydroxysteroid dehydrogenase type 14 in normal physiology and in breast cancer

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21